Evaluating The Relationship Between Blood Transfusion Time Points and Mortality in Patients with Bladder Cancer Undergoing Radical Cystectomy
Men's Health Journal,
Vol. 7 No. 1 (2023),
22 January 2023
,
Page e12
https://doi.org/10.22037/mhj.v7i1.43850
Abstract
Introduction: Radical cystectomy as a crucial treatment approach for high-grade bladder cancer is often associated with substantial blood loss and a frequent necessity for blood transfusion. Investigating the correlation between perioperative blood transfusion and surgical outcomes is an area of contention. We aimed to examine the relationship between blood transfusion timing and mortality in patients undergoing radical cystectomy. Materials and methods: The clinical records of 274 patients who underwent radical cystectomy at Modarres Hospital in Tehran, Iran, during 2011-2021 were reviewed. Among them, 191 patients received perioperative blood transfusions. The 90-day mortality rate was compared between these groups, and the association between transfusion timing and mortality was assessed. Results: The 90-day mortality rate was 14% in the blood recipient group and 11% in the non-transfusion group. However, no statistically significant relationship was observed between blood transfusion and 90-day mortality (P=0.4). The most prevalent timeframe for blood transfusion was before and during surgery. Mortality was highest in the group receiving blood before and during the operation, with a rate of 18%. Nevertheless, no statistically significant association was found between transfusion timing and mortality (P=0.346). When comparing the Charlson Comorbidity index (CCI) between the two groups, significantly higher CCI levels were observed in the blood recipient group (P=0.003). Conclusion: In our retrospective review, no significant relationship was identified between blood transfusion, its timing, surgical outcomes, and 90-day mortality. However, the blood recipient group had higher CCI scores compared to non-transfused patients.
- Radical cystectomy
- Blood transfusion
- Mortality
- Complication
How to Cite
References
- Masui K, Gini B, Wykosky J, Zanca C, Mischel PS, Furnari FB, et al. A tale of two approaches: complementary mechanisms of cytotoxic and targeted therapy resistance may inform next-generation cancer treatments. Carcinogenesis. 2013;34(4):725-38.
- Lorusso D, Bria E, Costantini A, Di Maio M, Rosti G, Mancuso A. Patients’ perception of chemotherapy side effects: Expectations, doctor–patient communication and impact on quality of life–An Italian survey. European journal of cancer care. 2017;26(2):e12618.
- Yun SJ, Kim S-K, Kim W-J. How do we manage high-grade T1 bladder cancer? Conservative or aggressive therapy? Investigative and clinical urology. 2016;57(Suppl 1):S44-S51.
- Martini A, Sfakianos JP, Renstrom-Koskela L, Mortezavi A, Falagario UG, Egevad L, et al. The natural history of untreated muscle-invasive bladder cancer. BJU international. 2019.
- Soleimani M, Moradkhani E, Masoumi N, Gholivandan J. Extra-Peritoneal versus Trans-Peritoneal Open Radical Cystectomy - Comparison of Two Techniques in Early Post-Operative Complications. Urol J. 2021 Nov 7;18(5):519-524. doi: 10.22037/uj.v16i7.6147. PMID: 32827149.
- Hosseini A, Adding C, Nilsson A, Jonsson MN, Wiklund NP. Robotic cystectomy: surgical technique. BJU Int. 2011 Sep;108(6 Pt 2):962-8. doi: 10.1111/j.1464-410X.2011.10566.x. PMID: 21917098.
- Diamantopoulos LN, Sekar RR, Holt SK, Khaki AR, Miller NJ, Gadzinski A, et al., editors. Patterns and timing of perioperative blood transfusion and association with outcomes after radical cystectomy. Urologic Oncology: Seminars and Original Investigations; 2021: Elsevier.
- Lee JS, Kim HS, Jeong CW, Kwak C, Kim HH, Ku JH. The prognostic impact of perioperative blood transfusion on survival in patients with bladder urothelial carcinoma treated with radical cystectomy. Korean journal of urology. 2015;56(4):295-304.
- Abel EJ, Linder BJ, Bauman TM, Bauer RM, Thompson RH, Thapa P, et al. Perioperative blood transfusion and radical cystectomy: does timing of transfusion affect bladder cancer mortality? European urology. 2014;66(6):1139-47.
- Moschini M, Dell'Oglio P, Capogrosso P, Cucchiara V, Luzzago S, Gandaglia G, et al. Effect of allogeneic intraoperative blood transfusion on survival in patients treated with radical cystectomy for nonmetastatic bladder cancer: results from a single high-volume institution. Clinical genitourinary cancer. 2015;13(6):562-7.
- Rivas JG, y Gregorio SA, Ledo JC, Gómez ÁT, Sebastián JD, de la Peña Barthel J. The role of perioperative blood transfusion on postoperative outcomes and overall survival in patients after laparoscopic radical cystectomy. Journal of cancer research and therapeutics. 2016;12(1):146.
- Abstract Viewed: 61 times
- pdf Downloaded: 52 times